Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - HER2-ADC
Get the latest updates from Google Alert - HER2-ADC directly as they happen.
Follow now 125 followers
Latest posts
Last updated 8 minutes ago
Unlocking a First-in-Class EGFR/HER3 ADC: Sichuan Biokin's Iza-Bren Poised to Transform ...
about 3 hours ago
Strategic Trial Designs Across Key Indications · ER+/HER2- Breast Cancer (2026): A...
Randomized phase 2 trial of neoadjuvant ARX788 + Pyrotinib vs TCHP for HER2+ BC - OncoDaily
about 11 hours ago
published in Nature: “Randomized phase 2 trial of neoadjuvant ARX788 (anti-microtubule HER2...
Bristol Myers' China partner touts Phase 3 success for EGFRxHER3 bispecific ADC
about 14 hours ago
AstraZeneca has its own franchise drug Enhertu (HER2-targeting ADC) and the recently...
Jazz Pharma's Ziihera Approved in Europe for HER2-Positive Biliary Tract Cancer
about 15 hours ago
Iksuda Therapeutics Expanding Phase I Trial of its HER2-Targeted ADC to US...
BlissBio Goes Solo On HER2-Targeting ADC After Eisai Exit - Citeline News & Insights
about 18 hours ago
Bliss Biopharmaceutical (Hangzhou) (BlissBio), a Chinese developer of antibody-drug conjugates (ADCs), will...
Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC ...
1 day ago
However, HER2 mutations account for only 3%–5% of CRC, and HER2-directed therapy...
New AI Tool Boosts Accuracy in HER2-Low and HER2-Ultralow Breast Cancer Scoring
1 day ago
... ADCs, HER2 directing ADCs. And we also detected an increase in...
Iksuda Therapeutics Expanding Phase I Trial of its HER2-Targeted ADC to US
1 day ago
NEW YORK – Iksuda Therapeutics on Monday said it will expand an...
Ziihera's EU Approval: Jazz Pharmaceuticals' Oncology Pivot Hits a Critical Milestone
1 day ago
Risks include delays in Phase 3 trials, potential competition (e.g., Roche's HER2...
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and ...
1 day ago
Antibody-drug conjugates (ADCs) and tyrosine kinase inhibitors (TKIs) are widely used for...
New stock news | Bailisi Kang has submitted an application to the Hong Kong Stock ...
1 day ago
The company's core product BB-1701 (core product) is a human epidermal growth...
Iksuda Therapeutics receives FDA IND clearance for IKS014 - PharmiWeb.com
2 days ago
... (HER2) ADC targeting patients with advanced HER2+ solid tumours, enabling the...